PMID- 27616197 OWN - NLM STAT- MEDLINE DCOM- 20170731 LR - 20191210 IS - 1879-0984 (Electronic) IS - 0166-0934 (Linking) VI - 237 DP - 2016 Nov TI - Development and evaluation of a new lateral flow assay for simultaneous detection of antibodies against African Horse Sickness and Equine Infectious Anemia viruses. PG - 127-131 LID - S0166-0934(16)30164-1 [pii] LID - 10.1016/j.jviromet.2016.09.009 [doi] AB - African horse sickness (AHS) and equine infectious anemia (EIA) are both notifiable equid specific diseases that may present similar clinical signs. Considering the increased global movement of horses and equine products over the past decades, together with the socio-economic impact of previous AHS and EIA outbreaks, there is a clear demand for an early discrimination and a strict control of their transmission between enzootic and AHS/EIA-free regions. Currently, the individual control and prevention of AHS or EIA relies on a series of measures, including the restriction of animal movements, vector control, and the use of several laboratory techniques for viral identification, amongst others. Despite being widely employed in surveillance programmes and in the control of animal movements, the available serological assays can only detect AHS- or EIA-specific antibodies individually. In this work, a duplex lateral flow assay (LFA) for simultaneous detection and differentiation of specific antibodies against AHS virus (AHSV) and EIA virus (EIAV) was developed and evaluated with experimental and field serum samples. The duplex LFA was based on the AHSV-VP7 outer core protein and the EIAV-P26 major core protein. The results indicated that the duplex LFA presented a good analytical performance, detecting simultaneously and specifically antibodies against AHSV and EIAV. The initial diagnostic evaluation revealed a good agreement with results from the AHS and EIA tests prescribed by the OIE, and it highlighted the usefulness of the new AHSV/EIAV duplex LFA for an on-field and point-of-care first diagnosis. CI - Copyright (c) 2016 Elsevier B.V. All rights reserved. FAU - Costa, Sofia AU - Costa S AD - Inmunologia y Genetica Aplicada S.A. (INGENASA), Madrid, Spain. FAU - Sastre, Patricia AU - Sastre P AD - Inmunologia y Genetica Aplicada S.A. (INGENASA), Madrid, Spain. FAU - Perez, Teresa AU - Perez T AD - Inmunologia y Genetica Aplicada S.A. (INGENASA), Madrid, Spain. FAU - Tapia, Istar AU - Tapia I AD - Inmunologia y Genetica Aplicada S.A. (INGENASA), Madrid, Spain. FAU - Barrandeguy, Maria AU - Barrandeguy M AD - Instituto de Virologia, CICVyA, INTA, Buenos Aires, Argentina; Escuela de Veterinaria, Universidad del Salvador, Buenos Aires, Argentina. FAU - Sanchez-Vizcaino, Jose M AU - Sanchez-Vizcaino JM AD - VISAVET Health Surveillance Centre, Spain; Animal Health Department, UCM, Spain. FAU - Sanchez-Matamoros, Almudena AU - Sanchez-Matamoros A AD - VISAVET Health Surveillance Centre, Spain; Animal Health Department, UCM, Spain. FAU - Wigdorovitz, Andres AU - Wigdorovitz A AD - Instituto de Virologia, CICVyA, INTA, Buenos Aires, Argentina. FAU - Sanz, Antonio AU - Sanz A AD - Inmunologia y Genetica Aplicada S.A. (INGENASA), Madrid, Spain. FAU - Rueda, Paloma AU - Rueda P AD - Inmunologia y Genetica Aplicada S.A. (INGENASA), Madrid, Spain. Electronic address: prueda@ingenasa.com. LA - eng PT - Evaluation Study PT - Journal Article DEP - 20160909 PL - Netherlands TA - J Virol Methods JT - Journal of virological methods JID - 8005839 RN - 0 (Antibodies, Viral) RN - 0 (Viral Core Proteins) RN - 0 (equine infectious anemia virus, p26) SB - IM MH - African Horse Sickness/*diagnosis/immunology MH - African Horse Sickness Virus/*immunology MH - Animals MH - Antibodies, Viral/*blood MH - Enzyme-Linked Immunosorbent Assay/*methods MH - Equine Infectious Anemia/*diagnosis/immunology MH - Horses MH - Infectious Anemia Virus, Equine/*immunology MH - Point-of-Care Systems MH - Viral Core Proteins/immunology OTO - NOTNLM OT - African horse sickness OT - Antibodies OT - Equine infectious anaemia OT - Lateral flow assay EDAT- 2016/09/13 06:00 MHDA- 2017/08/02 06:00 CRDT- 2016/09/13 06:00 PHST- 2016/04/04 00:00 [received] PHST- 2016/09/07 00:00 [revised] PHST- 2016/09/07 00:00 [accepted] PHST- 2016/09/13 06:00 [pubmed] PHST- 2017/08/02 06:00 [medline] PHST- 2016/09/13 06:00 [entrez] AID - S0166-0934(16)30164-1 [pii] AID - 10.1016/j.jviromet.2016.09.009 [doi] PST - ppublish SO - J Virol Methods. 2016 Nov;237:127-131. doi: 10.1016/j.jviromet.2016.09.009. Epub 2016 Sep 9.